News Releases
Announcement
BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDxᵀᴹ IN JAPAN
December 15, 2023
BioCheetah
Announcement
We are pleased to announce our strategic partnership with Wellesta for commercializing VECanDx™ ELISA test for early detection of bladder cancer.
September 26, 2023
BioCheetah
Announcement
BioCheetah receives ISO 13485:2016 certification for Medical Device Design and Development
September 15, 2021
BioCheetah
Announcement
Promising clinical trials aims to detect bladder cancer via a quick liquid biopsy test
May 20, 2020
BioCheetah
Announcement
BioCheetah clinched two awards at the Asian Entrepreneurship Awards 2019
January 24, 2020
BioCheetah
